BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35866187)

  • 1. Overcoming clinical challenges of refractory neuropathic pain.
    Pirvulescu I; Biskis A; Candido KD; Knezevic NN
    Expert Rev Neurother; 2022 Jul; 22(7):595-622. PubMed ID: 35866187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness and Safety of 42°C Pulsed Radiofrequency Combined with 60°C Continuous Radiofrequency for Refractory Infraorbital Neuralgia: A Prospective Study.
    Jia Y; Chen Z; Ren H; Luo F
    Pain Physician; 2019 May; 22(3):E171-E179. PubMed ID: 31151340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of intrathecal drug in the treatment of neuropathic pain - new research and opinion.
    Deer TR; Malinowski M; Varshney V; Pope J
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):1003-1007. PubMed ID: 31437412
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the interventional management of neuropathic pain.
    Varshney V; Osborn J; Chaturvedi R; Shah V; Chakravarthy K
    Ann Transl Med; 2021 Jan; 9(2):187. PubMed ID: 33569489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional Treatments for Postherpetic Neuralgia: A Systematic Review.
    Lin CS; Lin YC; Lao HC; Chen CC
    Pain Physician; 2019 May; 22(3):209-228. PubMed ID: 31151330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulation for chronic pain.
    Knotkova H; Hamani C; Sivanesan E; Le Beuffe MFE; Moon JY; Cohen SP; Huntoon MA
    Lancet; 2021 May; 397(10289):2111-2124. PubMed ID: 34062145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications.
    Patel S; Mittal R; Sarantopoulos KD; Galor A
    Expert Opin Ther Targets; 2022 Aug; 26(8):681-695. PubMed ID: 36069761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Caudal Epidural Pulsed Radiofrequency Stimulation in Patients with Refractory Chronic Idiopathic Axonal Polyneuropathy.
    Lee DG; Chang MC
    Pain Physician; 2018 Jan; 21(1):E57-E62. PubMed ID: 29357341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occipital Neuralgia.
    Pan W; Peng J; Elmofty D
    Curr Pain Headache Rep; 2021 Jul; 25(9):61. PubMed ID: 34287719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive procedures for neuropathic pain.
    Sdrulla A; Chen G
    Pain Manag; 2016 Apr; 6(2):103-9. PubMed ID: 26988024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Management of Corneal Neuropathic Pain with Intrathecal Targeted Drug Delivery.
    Hayek SM; Sweet JA; Miller JP; Sayegh RR
    Pain Med; 2016 Jul; 17(7):1302-7. PubMed ID: 26814286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions - a review of clinical trials.
    Knezevic NN; Jovanovic F; Candido KD; Knezevic I
    Expert Opin Pharmacother; 2020 Dec; 21(18):2231-2248. PubMed ID: 32772737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziconotide intrathecal delivery as treatment for secondary therapeutic failure of motor cortex stimulation after 6 years.
    Voirin J; Darie I; Fischer D; Simon A; Rohmer-Heitz I; Proust F
    Neurochirurgie; 2016 Oct; 62(5):284-288. PubMed ID: 27771111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.
    Deer TR; Mekhail N; Provenzano D; Pope J; Krames E; Leong M; Levy RM; Abejon D; Buchser E; Burton A; Buvanendran A; Candido K; Caraway D; Cousins M; DeJongste M; Diwan S; Eldabe S; Gatzinsky K; Foreman RD; Hayek S; Kim P; Kinfe T; Kloth D; Kumar K; Rizvi S; Lad SP; Liem L; Linderoth B; Mackey S; McDowell G; McRoberts P; Poree L; Prager J; Raso L; Rauck R; Russo M; Simpson B; Slavin K; Staats P; Stanton-Hicks M; Verrills P; Wellington J; Williams K; North R;
    Neuromodulation; 2014 Aug; 17(6):515-50; discussion 550. PubMed ID: 25112889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Mini-invasive Approach to the Treatment of Neuropathic Pain: The PENS Study.
    Rossi M; DeCarolis G; Liberatoscioli G; Iemma D; Nosella P; Nardi LF
    Pain Physician; 2016 Jan; 19(1):E121-8. PubMed ID: 26752480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine for neuropathic pain in adults.
    Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinued neuropathic pain therapy between 2009-2015.
    Knezevic NN; Cicmil N; Knezevic I; Candido KD
    Expert Opin Investig Drugs; 2015; 24(12):1631-46. PubMed ID: 26472477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.